Anwar Uddin, MD1, Prashil Dave, MD2, Peter Lymberopoulos, MD1, Madia Ahad, MD1, Rafat Uddin, BA1, Afgal Ahad, MD1, Rahat Uddin, MS1, Dipsa Shastri, MD3, Sahil Chaddha, MD, MS1, Narinderjeet Kaur, MD, MS1, Isabel Conde, MD2, Ammar Abdulfattah, MD1, Rita Offor, MD1, Sahil Zaveri, MD4, Syeda M. Ali, MD1, Justin Chung, MD4 1SUNY Downstate Medical Center, Brooklyn, NY; 2State University of New York Downstate, Brooklyn, NY; 3East Tennessee State University, Johnson City, TN; 4SUNY Downstate Health Sciences University, Brooklyn, NY
Introduction: Acute pancreatitis are frequently treated with opioids, but long-term risk for opioid use disorders (OUD) is not well known. The aim of present study is to examine one year risk of OUD after acute pancreatitis hospitalization using Nationwide Readmissions Database (NRD).
Methods: We used the Healthcare Cost and Utilization Project (HCUP) NRD to identify adult patients admitted with acute pancreatitis in 2016 using ICD-10-CM codes. We included only patients discharged in January to allow the 11 months of follow up to identify readmissions associated with OUD using ICD-10-CM codes. We used the survey based multivariate logistic regression model to identify the risk factors associated with OUD readmission.
Results: We identified a total of 22,488 index hospitalizations associated with acute pancreatitis in January 2016 in the United States and 1,610 (7.2%) of them were readmitted with OUD during 11 month follow up. Increasing age, having private medical insurance, and index admission at non-metropolitan hospital was associated with lower risk of OUD readmission while having ≥2 Charlson Comorbidity Index was associated with higher risk of OUD readmission (Table 2).
Discussion: Having higher number of co-morbidities is associated with long-term risk of OUD after acute pancreatitis.
Figure: OUD and Pancreatitis one year follow up
Note: The table for this abstract can be viewed in the ePoster Gallery section of the ACG 2024 ePoster Site or in The American Journal of Gastroenterology's abstract supplement issue, both of which will be available starting October 27, 2024.
Disclosures:
Anwar Uddin indicated no relevant financial relationships.
Prashil Dave indicated no relevant financial relationships.
Peter Lymberopoulos indicated no relevant financial relationships.
Madia Ahad indicated no relevant financial relationships.
Rafat Uddin indicated no relevant financial relationships.
Afgal Ahad indicated no relevant financial relationships.
Rahat Uddin indicated no relevant financial relationships.
Dipsa Shastri indicated no relevant financial relationships.
Sahil Chaddha indicated no relevant financial relationships.
Narinderjeet Kaur indicated no relevant financial relationships.
Isabel Conde indicated no relevant financial relationships.
Ammar Abdulfattah indicated no relevant financial relationships.
Rita Offor indicated no relevant financial relationships.
Sahil Zaveri indicated no relevant financial relationships.
Syeda Ali indicated no relevant financial relationships.
Justin Chung indicated no relevant financial relationships.
Anwar Uddin, MD1, Prashil Dave, MD2, Peter Lymberopoulos, MD1, Madia Ahad, MD1, Rafat Uddin, BA1, Afgal Ahad, MD1, Rahat Uddin, MS1, Dipsa Shastri, MD3, Sahil Chaddha, MD, MS1, Narinderjeet Kaur, MD, MS1, Isabel Conde, MD2, Ammar Abdulfattah, MD1, Rita Offor, MD1, Sahil Zaveri, MD4, Syeda M. Ali, MD1, Justin Chung, MD4. P0037 - One-Year Risk of Opioid Use Disorder After Hospitalization for Acute Pancreatitis, ACG 2024 Annual Scientific Meeting Abstracts. Philadelphia, PA: American College of Gastroenterology.
